Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 4.63 is 665% above its 5-year average of -0.82, near the high end of its 5-year range (-3.40–4.63).
276.42% above its 12-month average of 1.23.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 1.09.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:20:37.429Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
4.63
EARNINGS PER SHARE (EPS) AVG TTM
1.23
EARNINGS PER SHARE (EPS) AVG 3Y
0.09
EARNINGS PER SHARE (EPS) AVG 5Y
-0.82
EARNINGS PER SHARE (EPS) AVG 10Y
-0.14
EARNINGS PER SHARE (EPS) AVG 15Y
-0.53
EARNINGS PER SHARE (EPS) AVG 20Y
-4.92
CURRENT VS TTM AVG
+276.42%
CURRENT VS 3Y AVG
+5044.44%
CURRENT VS 5Y AVG
+664.63%
CURRENT VS 10Y AVG
+3510.80%
CURRENT VS 15Y AVG
+970.86%
CURRENT VS 20Y AVG
+194.04%
ANI Pharmaceuticals, Inc.
Market Cap
$1.65B
Earnings Per Share (EPS)
4.63
TTM Avg
1.23
3Y Avg
0.09
5Y Avg
-0.82
Market Cap
$1.65B
Earnings Per Share (EPS)
-0.72
TTM Avg
-1.04
3Y Avg
-1.27
5Y Avg
-1.30
Market Cap
$1.66B
Earnings Per Share (EPS)
-2.67
TTM Avg
-2.43
3Y Avg
-2.07
5Y Avg
-2.07
Market Cap
$1.71B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$1.57B
Earnings Per Share (EPS)
-0.44
TTM Avg
-0.04
3Y Avg
-0.09
5Y Avg
-0.12
Market Cap
$1.76B
Earnings Per Share (EPS)
0.19
TTM Avg
-0.34
3Y Avg
-0.57
5Y Avg
-0.59
Market Cap
$1.52B
Earnings Per Share (EPS)
0.38
TTM Avg
-0.16
3Y Avg
-0.18
5Y Avg
-0.35
Market Cap
$1.52B
Earnings Per Share (EPS)
4.10
TTM Avg
2.19
3Y Avg
2.59
5Y Avg
2.64
Market Cap
$1.52B
Earnings Per Share (EPS)
-1.00
TTM Avg
-0.77
3Y Avg
-0.59
5Y Avg
-0.43
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. (ANIP) | $1.65B | 4.63 | 1.23 | 0.09 | -0.82 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -0.72 | -1.04 | -1.27 | -1.30 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | -2.67 | -2.43 | -2.07 | -2.07 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -2.74 | -3.74 | -3.13 | -1.84 |
| Certara, Inc. (CERT)vs › | $1.57B | -0.44 | -0.04 | -0.09 | -0.12 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 0.19 | -0.34 | -0.57 | -0.59 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.38 | -0.16 | -0.18 | -0.35 |
| Innoviva, Inc. (INVA)vs › | $1.52B | 4.10 | 2.19 | 2.59 | 2.64 |
| GH Research PLC (GHRS)vs › | $1.52B | -1.00 | -0.77 | -0.59 | -0.43 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -3.36 | -4.53 | -5.16 | -4.47 |
Trailing EPS (TTM)
$4.63
Forward EPS (Est.)
$9.27
P/E Ratio
15.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 3.50 |
| 2024-12-31 | -1.04 |
| 2023-12-31 | 0.95 |
| 2022-12-31 | -3.05 |
| 2021-12-31 | -3.40 |
| 2020-12-31 | -1.88 |
| 2019-12-31 | 0.51 |
| 2018-12-31 | 1.33 |
| 2017-12-31 | -0.09 |
| 2016-12-31 | 0.34 |
| 2015-12-31 | 1.34 |
| 2014-12-31 | 2.61 |
| 2013-12-31 | -0.92 |
| 2012-12-31 | -7.64 |
| 2011-12-31 | -18.88 |
| 2010-12-31 | -25.23 |
| 2009-12-31 | -50.39 |
| 2008-12-31 | -22.97 |
| 2007-12-31 | -10.71 |
| 2006-12-31 | 4.68 |
| 2005-12-31 | -17.92 |
| 2004-12-31 | -25.23 |
| 2003-12-31 | -19.44 |
| 2002-12-31 | -18.28 |
| 2001-12-31 | -14.50 |
| 2000-12-31 | -21.51 |
| 1999-12-31 | -10.24 |
| 1998-12-31 | -0.27 |
